Therapeutic Targeting of Cellular Metabolism in Cells with Hyperactive mTORC1: A Paradigm Shift

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Cancer Research

• Publication date

  2014-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-14-0343PMID 25298408PMCID PMC4312527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.

  2014cited by this paper
• Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

  2014cited by this paper
• Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells

  2014cited by this paper
• mTOR and autophagy: a dynamic relationship governed by nutrients and energy.

  2014cited by this paper
• The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism.

  2014cited by this paper
• High-Throughput Drug Screen Identifies Chelerythrine as a Selective Inducer of Death in a TSC2-null Setting

  2014cited by this paper
• MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1

  2013cited by this paper
• Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide

  2013influential reference
• A growing role for mTOR in promoting anabolic metabolism.

  2013cited by this paper
• Nutrient regulation of the mTOR Complex 1 signaling pathway

  2013cited by this paper
• Power of Rare Diseases: Found in Translation

  2013cited by this paper
• Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma

  2013cited by this paper
• mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6

  2013cited by this paper
• Signal integration by mTORC1 coordinates nutrient input with biosynthetic output

  2013cited by this paper
• Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex.

  2013cited by this paper
• Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)

  2012cited by this paper
• Low glycemic index treatment for epilepsy in tuberous sclerosis complex.

  2012cited by this paper
• Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

  2012cited by this paper
• Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition

  2012cited by this paper
• Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1.

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Impaired autophagy due to constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress

  2011cited by this paper
• Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent

  2011cited by this paper
• Glucose deprivation in tuberous sclerosis complex-related tumors

  2011cited by this paper
• Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis

  2011cited by this paper
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

  2011cited by this paper
• Relieving Autophagy and 4EBP1 from Rapamycin Resistance

  2011cited by this paper
• Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.

  2011cited by this paper
• Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

  2011cited by this paper
• The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR

  2011cited by this paper
• Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia

  2011cited by this paper
• mTOR links oncogenic signaling to tumor cell metabolism

  2011cited by this paper
• Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

  2011cited by this paper
• Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

  2011cited by this paper
• Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

  2010cited by this paper
• Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.

  2010cited by this paper
• A metabolic (re-)balancing act.

  2010influential reference
• Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly*

  2010cited by this paper
• ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy

  2010cited by this paper
• CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability.

  2010cited by this paper
• Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice

  2010cited by this paper
• Activation of a metabolic gene regulatory network downstream of mTOR complex 1.

  2010cited by this paper
• Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

  2010influential reference
• A complex interplay between Akt, TSC2 and the two mTOR complexes.

  2009cited by this paper
• The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

  2008influential reference
• Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

  2008cited by this paper
• The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.

  2008cited by this paper
• Tel2 regulates the stability of PI3K-related protein kinases.

  2007cited by this paper
• Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif*

  2007cited by this paper
• The tuberous sclerosis complex.

  2006cited by this paper
• Tuberous Sclerosis Complex and the Ketogenic Diet

  2005cited by this paper
• Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

  2004cited by this paper
• Alkylating DNA damage stimulates a regulated form of necrotic cell death.

  2004cited by this paper
• Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.

  2003cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

  2000cited by this paper

• Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers.

  2025cites this paper
• The dual role of OTUD3 in cancer: mechanisms and therapeutic implications

  2025cites this paper
• Glutaminase - A potential target for cancer treatment

  2024cites this paper
• Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model

  2023cites this paper
• Perfect match: mTOR inhibitors and tuberous sclerosis complex

  2022cites this paper
• Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine

  2022cites this paper
• Understanding of black salve toxicity by multi-compound cytotoxicity assays

  2022cites this paper
• The paradox of autophagy in Tuberous Sclerosis Complex

  2021cites this paper
• Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML

  2021cites this paper
• Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma

  2020cites this paper
• Glutamine reliance in cell metabolism

  2020cites this paper
• Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

  2019cites this paper
• Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review

  2018cites this paper
• In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis.

  2018influential citation
• Mourning Dr. Alfred G. Knudson: the two‐hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex

  2017cites this paper
• mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation

  2017cites this paper
• Using genetic buffering relationships identified in fission yeast to reveal susceptibilities in cells lacking hamartin or tuberin function

  2017cites this paper
• Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.

  2017cites this paper
• Tuberous sclerosis--A model for tumour growth.

  2016cites this paper
• Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses

  2016cites this paper
• Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?

  2016cites this paper
• Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

  2016cites this paper
• Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies

  2016cites this paper
• Tuberous sclerosis complex

  2016cites this paper
• Molecular Pathways in Childhood Acute Lymphoblastic Leukemia: From the Bench to the Bedside

  2015cites this paper
• Title: Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from type 2 diabetics

  2015cites this paper
• Glutaminolysis and autophagy in cancer

  2015cites this paper
• Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi

  2015cites this paper
• Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics.

  2015cites this paper
• Outlook on PI3K/AKT/mTOR inhibition in acute leukemia

  2015cites this paper
• Oncogenes strike a balance between cellular growth and homeostasis.

  2015cites this paper
• Unbiased Combinatorial Genomic Approaches to Identify Alternative Therapeutic Targets within the TSC Signaling Network

  2014cites this paper